Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 07 Mar 2024 for Ambrx Biopharma, Inc..
Filing timeline
BuySaleSonja Nelson
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sonja Nelson: trading record in brief
This profile gathers the share dealings of Sonja Nelson across 4 companies, led by ImmunityBio, Inc., Ambrx Biopharma, Inc. and Motus GI Holdings, Inc. In total, 17 filings cover trades dated from 23 March 2018 to 7 March 2024.
No open-market purchase appears, only 3 sales worth €757k. Other entries cover 7 share grants and 6 option exercises.
The latest filing, published on 7 March 2024, reports a transaction in Ambrx Biopharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sonja Nelson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
22,936 sharesCommon StockSEC:0000950170-24-028182:0
50,000 shares0Common StockSEC:0000950170-23-069447:0
12,778 shares@ US$9.82100.0% of flowCommon StockSEC:0000950170-23-056944:0
1,000,000 shares0Ordinary SharesSEC:0001209191-23-026101:0
82,500 shares0Common Stock, par value $0.0001 per shareSEC:0001493152-22-000691:0
18,209 shares0Common Stock, par value $0.0001 per shareSEC:0001213900-21-033779:0
6 of 6 declarations
